Terms: = Colorectal cancer AND ERCC2, TTD, 2068, ENSG00000104884, COFS2, P18074, MGC102762, XPD, MGC126219, MGC126218, EM9 AND Diagnosis
12 results:
1. Real-world evidence of trifluridine/tipiracil plus bevacizumab in metastatic colorectal cancer using an administrative claims database in Japan.
Kagawa Y; Shinozaki E; Okude R; Tone T; Kunitomi Y; Nakashima M
ESMO Open; 2023 Aug; 8(4):101614. PubMed ID: 37562196
[TBL] [Abstract] [Full Text] [Related]
2. SEOM-GEMCAD-ttd clinical guidelines for the systemic treatment of metastatic colorectal cancer (2022).
Fernández Montes A; Alonso V; Aranda E; Élez E; García Alfonso P; Grávalos C; Maurel J; Vera R; Vidal R; Aparicio J
Clin Transl Oncol; 2023 Sep; 25(9):2718-2731. PubMed ID: 37133732
[TBL] [Abstract] [Full Text] [Related]
3. Development of a Correlative Strategy To Discover colorectal Tumor Tissue Derived Metabolite Biomarkers in Plasma Using Untargeted Metabolomics.
Wang Z; Cui B; Zhang F; Yang Y; Shen X; Li Z; Zhao W; Zhang Y; Deng K; Rong Z; Yang K; Yu X; Li K; Han P; Zhu ZJ
Anal Chem; 2019 Feb; 91(3):2401-2408. PubMed ID: 30580524
[TBL] [Abstract] [Full Text] [Related]
4. Thinking out of the
Koh FH; Chan HL; Petersson F; Chong CS
Gut; 2017 Dec; 66(12):2068-2159. PubMed ID: 27965282
[TBL] [Abstract] [Full Text] [Related]
5. Evaluating Ultra-long-Chain Fatty Acids as Biomarkers of colorectal cancer Risk.
Perttula K; Edmands WM; Grigoryan H; Cai X; Iavarone AT; Gunter MJ; Naccarati A; Polidoro S; Hubbard A; Vineis P; Rappaport SM
Cancer Epidemiol Biomarkers Prev; 2016 Aug; 25(8):1216-23. PubMed ID: 27257090
[TBL] [Abstract] [Full Text] [Related]
6. Social inequalities and cancer: can the European deprivation index predict patients' difficulties in health care access? a pilot study.
Moriceau G; Bourmaud A; Tinquaut F; Oriol M; Jacquin JP; Fournel P; Magné N; Chauvin F
Oncotarget; 2016 Jan; 7(1):1055-65. PubMed ID: 26540571
[TBL] [Abstract] [Full Text] [Related]
7. Association of APE1 and hOGG1 polymorphisms with colorectal cancer risk in a Turkish population.
Canbay E; Cakmakoglu B; Zeybek U; Sozen S; Cacina C; Gulluoglu M; Balik E; Bulut T; Yamaner S; Bugra D
Curr Med Res Opin; 2011 Jul; 27(7):1295-302. PubMed ID: 21561390
[TBL] [Abstract] [Full Text] [Related]
8. ttd consensus document on the diagnosis and management of hereditary colorectal cancer.
Pérez Segura P; Guillén Ponce C; Ramón y Cajal T; Serrano Blanch R; Aranda E
Clin Transl Oncol; 2010 May; 12(5):356-66. PubMed ID: 20466620
[TBL] [Abstract] [Full Text] [Related]
9. Genotype phenotype correlations in Israeli colorectal cancer patients.
Starinsky S; Figer A; Ben-Asher E; Geva R; Flex D; Fidder HH; Zidan J; Lancet D; Friedman E
Int J Cancer; 2005 Mar; 114(1):58-73. PubMed ID: 15523694
[TBL] [Abstract] [Full Text] [Related]
10. Implications of genetic testing in the management of colorectal cancer.
Stoehlmacher J; Lenz HJ
Am J Pharmacogenomics; 2003; 3(2):73-88. PubMed ID: 12749725
[TBL] [Abstract] [Full Text] [Related]
11. [Treatment of febrile neutropenia in patients with solid tumors].
Novotný J; Petruzelka L; Jedlicková A; Mikolásová B
Cas Lek Cesk; 1998 Nov; 137(22):694-9. PubMed ID: 9929937
[TBL] [Abstract] [Full Text] [Related]
12. Staging of invasive cervical carcinoma and of pelvic lymph nodes by high resolution MRI with a phased-array coil in comparison with pathological findings.
Hawighorst H; Schoenberg SO; Knapstein PG; Knopp MV; Schaeffer U; Essig M; van Kaick G
J Comput Assist Tomogr; 1998; 22(1):75-81. PubMed ID: 9448765
[TBL] [Abstract] [Full Text] [Related]
